Title:
【発明の名称】ヘルペスウイルス組換えポックスウイルスワクチン
Document Type and Number:
Japanese Patent JPH04505248
Kind Code:
A
Abstract:
What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.
Inventors:
Paoletti, Enzo
Application Number:
JP50707890A
Publication Date:
September 17, 1992
Filing Date:
April 16, 1990
Export Citation:
Assignee:
Health Research Inc.
International Classes:
A61K39/12; A61K39/245; A61K39/275; A61P31/12; A61P31/22; C07K14/02; C07K14/03; C07K14/035; C07K14/045; C07K14/05; C07K14/065; C07K14/11; C07K14/125; C07K14/145; C07K14/15; C07K14/165; C12N7/00; C12N7/01; C12N15/09; C12N15/38; C12N15/39; C12N15/863; C12P21/02; A61K38/00; A61K39/00; C12R1/91; (IPC1-7): A61K39/245; A61K39/275; C12N7/01; C12N15/38; C12N15/86; C12P21/02
Attorney, Agent or Firm:
Yuzo Yamazaki (2 outside)